Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$819M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$783M |
| 3 |
Apple
AAPL
|
+$750M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$605M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$484M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.72B |
| 2 |
TransUnion
TRU
|
+$1.09B |
| 3 |
Amazon
AMZN
|
+$1.05B |
| 4 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$451M |
| 5 |
Wells Fargo
WFC
|
+$385M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.29% |
| 2 | Financials | 10.73% |
| 3 | Healthcare | 9.01% |
| 4 | Consumer Discretionary | 8.24% |
| 5 | Industrials | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4726
BioXcel Therapeutics
BTAI
$26.9M
| $285K | ﹤0.01% |
+1,743
| New | +$291K |
|
4727
Natural Health Trends
NHTC
$15.1M
| $285K | ﹤0.01% |
15,004
-13,239
| -47% | -$224K |
|
|
MARK
4728
PUT
DELISTED
Remark Holdings, Inc.
MARK
| $285K | ﹤0.01% |
+5,020
| New | +$464K |
|
|
RSX
4729
PUT
DELISTED
VanEck Russia ETF
RSX
| $284K | ﹤0.01% |
12,500
-174,700
| -93% | -$4.01M |
|
4730
Mistras Group
MG
$503M
| $282K | ﹤0.01% |
14,914
+2,843
| +24% | +$58.7K |
|
|
VTLE
4731
PUT
DELISTED
Vital Energy
VTLE
| $282K | ﹤0.01% |
+1,620
| New | +$302K |
|
|
ARA
4732
DELISTED
American Renal Associates Holdings, Inc
ARA
| $282K | ﹤0.01% |
14,970
+1,288
| +9% | +$25.4K |
|
4733
Ocular Therapeutix
OCUL
$1.88B
| $281K | ﹤0.01% |
43,124
+8,157
| +23% | +$45.9K |
|
|
VSI
4734
DELISTED
Vitamin Shoppe Inc.
VSI
| $281K | ﹤0.01% |
64,531
-64,622
| -50% | -$282K |
|
|
LJPC
4735
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $281K | ﹤0.01% |
9,428
-18,246
| -66% | -$588K |
|
4736
CALL
Weyerhaeuser
WY
$18.2B
| $280K | ﹤0.01% |
8,000
-22,500
| -74% | -$794K |
|
|
PTE
4737
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $280K | ﹤0.01% |
+619
| New | +$313K |
|
|
ALXN
4738
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
| $279K | ﹤0.01% |
2,500
-57,200
| -96% | -$6.84M |
|
4739
STRATTEC Security
STRT
$368M
| $277K | ﹤0.01% |
+7,484
| New | +$289K |
|
|
RPT
4740
Rithm Property Trust
RPT
$94.2M
| $277K | ﹤0.01% |
3,524
-1,225
| -26% | -$95K |
|
|
MULE
4741
CALL
DELISTED
MuleSoft, Inc.
MULE
| $277K | ﹤0.01% |
+6,300
| New | +$187K |
|
4742
PUT
XPO
XPO
$23.7B
| $275K | ﹤0.01% |
7,807
-86,452
| -92% | -$2.88M |
|
|
NEOS
4743
DELISTED
Neos Therapeutics, Inc
NEOS
| $275K | ﹤0.01% |
33,135
-2,506
| -7% | -$23.9K |
|
|
FNSR
4744
CALL
DELISTED
Finisar Corp
FNSR
| $275K | ﹤0.01% |
17,400
-93,000
| -84% | -$1.76M |
|
4745
PUT
Zillow
Z
$8.15B
| $274K | ﹤0.01% |
+5,100
| New | +$246K |
|
4746
CALL
Advance Auto Parts
AAP
$3.42B
| $273K | ﹤0.01% |
2,300
-37,600
| -94% | -$4.3M |
|
4747
PUT
Helmerich & Payne
HP
$3.45B
| $273K | ﹤0.01% |
4,100
-173,700
| -98% | -$11.7M |
|
|
SBBP
4748
DELISTED
Strongbridge Biopharma plc.
SBBP
| $272K | ﹤0.01% |
30,752
-6,793
| -18% | -$50.9K |
|
|
BGC
4749
PUT
DELISTED
General Cable Corporation
BGC
| $272K | ﹤0.01% |
9,200
-2,100
| -19% | -$62.2K |
|
4750
Assembly Biosciences
ASMB
$509M
| $271K | ﹤0.01% |
460
-177
| -28% | -$110K |
|
Similar funds
Goldman Sachs's Q1 2018 Portfolio in Review
As of Q1 2018, Goldman Sachs held 6,750 positions worth $391B, down 6.5% from $418B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs withdrew a net $24B in Q1 2018, closing 894 positions and reducing 2,785 holdings. Its most notable exit was TransUnion, an estimated $1.09B position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 10% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Goldman Sachs opened a new position in Americold worth $454M.
- Goldman Sachs's largest Q1 2018 buy was Americold: 23,769,508 shares worth $454M.
- Goldman Sachs added most to Microsoft in Q1 2018, an estimated $819M increase.
- Goldman Sachs's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.72B.
- Goldman Sachs fully exited TransUnion in Q1 2018, selling an estimated $1.09B.
- Goldman Sachs's ten largest holdings make up 14% of its $391B portfolio in Q1 2018.
- Goldman Sachs opened 453 new positions and closed 894 in Q1 2018.
- Goldman Sachs's portfolio value fell 6.5% quarter-over-quarter to $391B.
Based on Goldman Sachs's 13F filing for Q1 2018, filed 15 May 2018.